Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine
This study is ongoing, but not recruiting participants.
Sponsor:
Program for Appropriate Technology in Health
Collaborators:
Microgen Scientific Industrial Company for immunobiological Medicines
Institute of Experimental Medicine, Russia
Information provided by (Responsible Party):
Program for Appropriate Technology in Health
ClinicalTrials.gov Identifier:
NCT01719783
First received: October 26, 2012
Last updated: October 30, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2013 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |